The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

Despite a robust cash position, Revolution Medicines' high burn rate and lofty valuation increase risk and sensitivity to ...

Biogen’s “Friedreich’s Back” Takes Top Honors in Pharma; 21GRAMS Named No. 2 Healthcare Agency and Real Chemistry Ranked No. 2 Healthcare Network Globally on Creative Community’s Biggest Stage CANNES, ...

(Photo: Getty Images) Generic versions of the popular diabetes drug Empagliflozin have reached the market after Boehringer Ingelheim's patent expired on March 11. The German pharmaceutical company ...

Mankind Pharma Limited on Thursday announced that it has entered into a partnership with Innovent Biologics to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy ...

Mankind Pharma on Tuesday announced that it has executed a Business Transfer Agreement (BTA) to transfer its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind ...

Joy Chatterjee has been elevated as Vice President and Head of Sales and Marketing at Mankind Pharma. He was earlier Associate Vice President. Joy Chatterjee has been with Mankind Pharma for ...

The acquisition is anticipated to bolster Mankind Pharma’s position in the Indian women’s health and fertility drug market. Credit: fizkes / Shutterstock. Mankind Pharma has announced a definitive ...

Mankind Pharma has clinched the deal to acquire Bharat Serums and Vaccines from private equity firm Advent International for ₹13,630 crore, the company said in a release. The Delhi-based pharma ...

Mankind Pharma Ltd. is emerging as the frontrunner to acquire Bharat Serums & Vaccines Ltd. in a deal that could value the target company at around $1.5 billion, according to people with knowledge ...

July 25 (Reuters) - Indian drugmaker Mankind Pharma (MNKI.NS), opens new tab said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ...